{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:36:04Z","timestamp":1788910564020,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Idiopathic choroidal neovascularization (ICNV) is a disorder that primarily affecting patients younger than 50 years and can cause severe loss of vision. Choroidal abnormalities, especially choroidal inflammation, have been thought to be involved in the pathophysiology of ICNV. However, the exact pathogenesis of ICNV remains unclear. The aim of our study was investigate the levels of 27 inflammatory cytokines in the aqueous humor of eyes with ICNV and to determine the effect of intravitreal injection of ranibizumab (IVR) on cytokine levels. Significantly higher levels of IL-2, IL-10, IL-15, IL-17, basic FGF and GM-CSF were observed in patients with ICNV compared with controls. However, only IL-17 levels were significantly higher in patients with ICNV compared with controls after adjusting for axial length. Furthermore, there were significant correlations between the levels of IL-10, IL-17, GM-CSF and VEGF and the lesion area. Significant changes in visual acuity and central retinal thickness were observed after IVR. Besides VEGF, IVR also significantly reduced the levels of IL-2, IL-10, basic FGF and IL-12, however, the IL-6 levels were significantly increased. Our results suggest that there may be an involvement of IL-17-related inflammatory processes in the etiology of ICNV.<\/jats:p>","DOI":"10.1038\/srep31880","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T09:04:22Z","timestamp":1472115862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment"],"prefix":"10.1038","volume":"6","author":[{"given":"Houfa","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenchao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"BFsrep31880_CR1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0161-6420(86)33609-1","volume":"93","author":"WR Green","year":"1986","unstructured":"Green, W. R. & Wilson, D. J. Choroidal neovascularization. Ophthalmology 93, 1169\u20131176 (1986).","journal-title":"Ophthalmology"},{"key":"BFsrep31880_CR2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2003.09.042","volume":"137","author":"HE Grossniklaus","year":"2004","unstructured":"Grossniklaus, H. E. & Green, W. R. Choroidal neovascularization. Am J Ophthalmol 137, 496\u2013503 (2004).","journal-title":"Am J Ophthalmol"},{"key":"BFsrep31880_CR3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","volume":"103","author":"SY Cohen","year":"1996","unstructured":"Cohen, S. Y., Laroche, A., Leguen, Y., Soubrane, G. & Coscas, G. J. Etiology of choroidal neovascularization in young patients. Ophthalmology 103, 1241\u20131244 (1996).","journal-title":"Ophthalmology"},{"key":"BFsrep31880_CR4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0161-6420(95)30968-2","volume":"102","author":"AC Ho","year":"1995","unstructured":"Ho, A. C., Yannuzzi, L. A., Pisicano, K. & DeRosa, J. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 102, 782\u2013789 (1995).","journal-title":"Ophthalmology"},{"key":"BFsrep31880_CR5","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1167\/iovs.08-1900","volume":"50","author":"M Sasahara","year":"2009","unstructured":"Sasahara, M., Otani, A., Yodoi, Y. & Yoshimura, N. Circulating hematopoietic stem cells in patients with idiopathic choroidal neovascularization. Invest Ophthalmol Vis Sci 50, 1575\u20131579 (2009).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep31880_CR6","doi-asserted-by":"crossref","unstructured":"Lee, J. E. et al. Topographical relationship between the choroidal watershed zone and submacular idiopathic choroidal neovascularisation. Br J Ophthalmol (2015).","DOI":"10.1136\/bjophthalmol-2015-306678"},{"key":"BFsrep31880_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000310714","volume":"210","author":"M Inagaki","year":"1996","unstructured":"Inagaki, M., Harada, T., Kiribuchi, T., Ohashi, T. & Majima, J. Subfoveal choroidal neovascularization in uveitis. Ophthalmologica 210, 229\u2013233 (1996).","journal-title":"Ophthalmologica"},{"key":"BFsrep31880_CR8","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/IAE.0000000000000491","volume":"35","author":"A Sudhalkar","year":"2015","unstructured":"Sudhalkar, A., Yogi, R. & Chhablani, J. Anti-Vascular Endothelial Growth Factor Therapy for Naive Idiopathic Choroidal Neovascularization: A Comparative Study. Retina 35, 1368\u20131374 (2015).","journal-title":"Retina"},{"key":"BFsrep31880_CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajo.2011.07.019","volume":"153","author":"H Zhang","year":"2012","unstructured":"Zhang, H., Liu, Z. L., Sun, P. & Gu, F. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial. Am J Ophthalmol 153, 300\u2013306, e301 (2012).","journal-title":"Am J Ophthalmol"},{"key":"BFsrep31880_CR10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajo.2012.10.010","volume":"155","author":"HM Kang","year":"2013","unstructured":"Kang, H. M. & Koh, H. J. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Am J Ophthalmol 155, 713\u2013719, 719 e711 (2013).","journal-title":"Am J Ophthalmol"},{"key":"BFsrep31880_CR11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/09273948.2010.483315","volume":"18","author":"F Yang","year":"2010","unstructured":"Yang, F. et al. Serum inflammatory factors in patients with idiopathic choroidal neovascularization. Ocul Immunol Inflamm 18, 390\u2013394 (2010).","journal-title":"Ocul Immunol Inflamm"},{"key":"BFsrep31880_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma, H. et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 22, 42\u201348 (2008).","journal-title":"Eye (Lond)"},{"key":"BFsrep31880_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","volume":"243","author":"H Funatsu","year":"2005","unstructured":"Funatsu, H. et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 243, 3\u20138 (2005).","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFsrep31880_CR14","first-page":"353","volume":"58","author":"JZ Nowak","year":"2006","unstructured":"Nowak, J. Z. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58, 353\u2013363 (2006).","journal-title":"Pharmacol Rep"},{"key":"BFsrep31880_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2014.10.005","volume":"21","author":"A Sene","year":"2015","unstructured":"Sene, A., Chin-Yee, D. & Apte, R. S. Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol Med 21, 43\u201351 (2015).","journal-title":"Trends Mol Med"},{"key":"BFsrep31880_CR16","doi-asserted-by":"crossref","first-page":"23794","DOI":"10.1038\/srep23794","volume":"6","author":"B Coughlin","year":"2016","unstructured":"Coughlin, B. et al. Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and gammadeltaT-cells. Sci Rep 6, 23794 (2016).","journal-title":"Sci Rep"},{"key":"BFsrep31880_CR17","doi-asserted-by":"crossref","first-page":"15702","DOI":"10.1038\/srep15702","volume":"5","author":"X Tan","year":"2015","unstructured":"Tan, X. et al. Choroidal neovascularization is inhibited via an intraocular decrease of inflammatory cells in mice lacking complement component C3. Sci Rep 5, 15702 (2015).","journal-title":"Sci Rep"},{"key":"BFsrep31880_CR18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","volume":"13","author":"A Amadi-Obi","year":"2007","unstructured":"Amadi-Obi, A. et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1. Nat Med 13, 711\u2013718 (2007).","journal-title":"Nat Med"},{"key":"BFsrep31880_CR19","doi-asserted-by":"crossref","first-page":"ii116","DOI":"10.1136\/annrheumdis-2012-202371","volume":"72","author":"DD Patel","year":"2013","unstructured":"Patel, D. D., Lee, D. M., Kolbinger, F. & Antoni, C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 72 Suppl 2, ii116\u2013ii123 (2013).","journal-title":"Ann Rheum Dis"},{"key":"BFsrep31880_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.imlet.2004.11.012","volume":"98","author":"H Takahashi","year":"2005","unstructured":"Takahashi, H., Numasaki, M., Lotze, M. T. & Sasaki, H. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett 98, 189\u2013193 (2005).","journal-title":"Immunol Lett"},{"key":"BFsrep31880_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-1","volume":"9","author":"B Liu","year":"2011","unstructured":"Liu, B. et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med 9, 1\u201312 (2011).","journal-title":"J Transl Med"},{"key":"BFsrep31880_CR22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.celrep.2012.10.013","volume":"2","author":"L Wei","year":"2012","unstructured":"Wei, L. et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep 2, 1151\u20131158 (2012).","journal-title":"Cell Rep"},{"key":"BFsrep31880_CR23","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4049\/jimmunol.1202495","volume":"190","author":"E Hasegawa","year":"2013","unstructured":"Hasegawa, E. et al. IL-23-independent induction of IL-17 from gammadeltaT cells and innate lymphoid cells promotes experimental intraocular neovascularization. J Immunol 190, 1778\u20131787 (2013).","journal-title":"J Immunol"},{"key":"BFsrep31880_CR24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","volume":"62","author":"MC Genovese","year":"2010","unstructured":"Genovese, M. C. et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 62, 929\u2013939 (2010).","journal-title":"Arthritis Rheum"},{"key":"BFsrep31880_CR25","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.4049\/jimmunol.1301737","volume":"192","author":"CB Russell","year":"2014","unstructured":"Russell, C. B. et al. Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol 192, 3828\u20133836 (2014).","journal-title":"J Immunol"},{"key":"BFsrep31880_CR26","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.ophtha.2009.05.039","volume":"116","author":"M Funk","year":"2009","unstructured":"Funk, M. et al. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 116, 2393\u20132399 (2009).","journal-title":"Ophthalmology"},{"key":"BFsrep31880_CR27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/aos.12770","volume":"93","author":"S Fauser","year":"2015","unstructured":"Fauser, S., Viebahn, U. & Muether, P. S. Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration. Acta Ophthalmol 93, 734\u2013738 (2015).","journal-title":"Acta Ophthalmol"},{"key":"BFsrep31880_CR28","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archophthalmol.2010.227","volume":"128","author":"JB Jonas","year":"2010","unstructured":"Jonas, J. B., Tao, Y., Neumaier, M. & Findeisen, P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 128, 1281\u20131286 (2010).","journal-title":"Arch Ophthalmol"},{"key":"BFsrep31880_CR29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/IAE.0b013e318285cd9e","volume":"33","author":"PS Muether","year":"2013","unstructured":"Muether, P. S. et al. Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration. Retina 33, 1809\u20131814 (2013).","journal-title":"Retina"},{"key":"BFsrep31880_CR30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","volume":"29","author":"MI Roh","year":"2009","unstructured":"Roh, M. I. et al. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina 29, 523\u2013529 (2009).","journal-title":"Retina"},{"key":"BFsrep31880_CR31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000365487","volume":"53","author":"Y Sakurada","year":"2015","unstructured":"Sakurada, Y. et al. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Ophthalmic Res 53, 2\u20137 (2015).","journal-title":"Ophthalmic Res"},{"key":"BFsrep31880_CR32","first-page":"1929","volume":"37","author":"A Kvanta","year":"1996","unstructured":"Kvanta, A., Algvere, P. V., Berglin, L. & Seregard, S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37, 1929\u20131934 (1996).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep31880_CR33","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.4049\/jimmunol.172.7.4618","volume":"172","author":"F Mor","year":"2004","unstructured":"Mor, F., Quintana, F. J. & Cohen, I. R. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172, 4618\u20134623 (2004).","journal-title":"J Immunol"},{"key":"BFsrep31880_CR34","first-page":"397","volume":"32","author":"K Ohtani","year":"2008","unstructured":"Ohtani, K. et al. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6. Int J Oncol 32, 397\u2013403 (2008).","journal-title":"Int J Oncol"},{"key":"BFsrep31880_CR35","doi-asserted-by":"crossref","first-page":"e3381","DOI":"10.1371\/journal.pone.0003381","volume":"3","author":"DS Dace","year":"2008","unstructured":"Dace, D. S., Khan, A. A., Kelly, J. & Apte, R. S. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. Plos One 3, e3381 (2008).","journal-title":"Plos One"},{"key":"BFsrep31880_CR36","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1371\/journal.pmed.0030310","volume":"3","author":"RS Apte","year":"2006","unstructured":"Apte, R. S., Richter, J., Herndon, J. & Ferguson, T. A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3, e310 (2006).","journal-title":"PLoS Med"},{"key":"BFsrep31880_CR37","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/1078-0432.CCR-11-0659","volume":"17","author":"C Lieu","year":"2011","unstructured":"Lieu, C., Heymach, J., Overman, M., Tran, H. & Kopetz, S. Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis. Clin Cancer Res 17, 6130\u20136139 (2011).","journal-title":"Clin Cancer Res"},{"key":"BFsrep31880_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","volume":"2","author":"R Simo","year":"2006","unstructured":"Simo, R., Carrasco, E., Garcia-Ramirez, M. & Hernandez, C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2, 71\u201398 (2006).","journal-title":"Curr Diabetes Rev"},{"key":"BFsrep31880_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1600-0420.2007.01074.x","volume":"86","author":"M Shimura","year":"2008","unstructured":"Shimura, M. et al. Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol 86, 377\u2013384 (2008).","journal-title":"Acta Ophthalmol"},{"key":"BFsrep31880_CR40","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00417-009-1147-x","volume":"247","author":"M Shimura","year":"2009","unstructured":"Shimura, M. et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 247, 1617\u20131624 (2009).","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFsrep31880_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-2478(93)90078-G","volume":"35","author":"C Holzinger","year":"1993","unstructured":"Holzinger, C. et al. Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte\/macrophage colony stimulating factor on human vascular endothelial cells. Immunol Lett 35, 109\u2013117 (1993).","journal-title":"Immunol Lett"},{"key":"BFsrep31880_CR42","doi-asserted-by":"crossref","unstructured":"Carreno, E. et al. Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes. Br J Ophthalmol (2015).","DOI":"10.1136\/bjophthalmol-2015-307806"},{"key":"BFsrep31880_CR43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.peptides.2015.04.025","volume":"69","author":"F Yang","year":"2015","unstructured":"Yang, F., Bai, Y. & Jiang, Y. Effects of Apelin on RAW264.7 cells under both normal and hypoxic conditions. Peptides 69, 133\u2013143 (2015).","journal-title":"Peptides"},{"key":"BFsrep31880_CR44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ophtha.2010.08.008","volume":"118","author":"M Zhang","year":"2011","unstructured":"Zhang, M. et al. A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Ophthalmology 118, 672\u2013678 (2011).","journal-title":"Ophthalmology"},{"key":"BFsrep31880_CR45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.11-7689","volume":"53","author":"SS Wickremasinghe","year":"2012","unstructured":"Wickremasinghe, S. S., Busija, L., Guymer, R. H., Wong, T. Y. & Qureshi, S. Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD. Invest Ophthalmol Vis Sci 53, 37\u201341 (2012).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep31880_CR46","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1167\/iovs.12-10123","volume":"53","author":"N Nagarkatti-Gude","year":"2012","unstructured":"Nagarkatti-Gude, N., Bronkhorst, I. H., van Duinen, S. G., Luyten, G. P. & Jager, M. J. Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma. Invest Ophthalmol Vis Sci 53, 6748\u20136755 (2012).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep31880_CR47","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1167\/iovs.11-9244","volume":"53","author":"K Nagata","year":"2012","unstructured":"Nagata, K. et al. Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis. Invest Ophthalmol Vis Sci 53, 3827\u20133833 (2012).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep31880_CR48","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","volume":"116","author":"T Sato","year":"2009","unstructured":"Sato, T., Kusaka, S., Shimojo, H. & Fujikado, T. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology 116, 2165\u20132169 (2009).","journal-title":"Ophthalmology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep31880","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T20:38:09Z","timestamp":1672864689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep31880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,10,17]]}},"alternative-id":["BFsrep31880"],"URL":"https:\/\/doi.org\/10.1038\/srep31880","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]},"assertion":[{"value":"13 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31880"}}